Increased Risk of Tourette Syndrome with Leukotriene Modifier Use in Children with Allergic Diseases and Asthma: A Nationwide Population-Based Study

• Главные авторы: Min-Lan Tsai (Автор), Hsiu-Chen Lin (Автор), Chiung-Hui Yen (Автор), Jung-Tzu Ku (Автор), Shian-Ying Sung (Автор), Hsi Chang (Автор)
• Формат: ‌
• Опубликовано: MDPI AG, 2022-10-01T00:00:00Z.
• Предметы: article
• Online-ссылка: Connect to this object online.

(1) Background: Cysteinyl leukotriene receptor antagonists (LTRAs), including montelukast and zafirlukast, are FDA-approved for treating pediatric asthma and allergic diseases. Tourette syndrome (TS), a common neuropsychiatric disorder in children, is associated with allergic diseases and asthma. In...